Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Pediatr Neurol. 2013 Nov 21;51(5):675–680. doi: 10.1016/j.pediatrneurol.2013.11.009

Table 1.

Subject Demographics

Stimulant Group

Total subjects 12

Gender
    Male/Female 7/5

Mean Age when stimulant started (range) 10.5 years (59 - 255 months)

Median Duration of time on stimulants (range) 24.5 months (2 month - 90 months)

Brain Involvement
    Left/Right/Bilateral 7/2/3

Symptoms
    Seizures 12 (100%)
    Hemiparesis 8 (67%)
    Headaches 8 (67%)
    Visual Field Deficit 6 (50%)

Additional Medications
    Aspirin 9 (75%)
    Oxcarbazepine 6 (50%)
    Carbamezipine 3 (25%)
    Valproic Acid 3 (25%)
    Levitiracetam 2 (17%)
    Lamotrigine 1 (8%)
    Topiramate 1 (8%)
    Felbamate 1 (8%)